Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Marc Schmalzing, MD

University Hospital Wuerzburg
Würzburg, Germany

June 2000 – June 2012 Medical Doctor at University Hospital Tuebingen, Internal Medicine, Hematology, Rheumatology
August 2012 – March 2022 Consultant, Deputy of head of Rheumatology/Clinical Immunology at University Hospital Wuerzburg, Department of Internal Medicine II
April 2022 – ongoing Consultant, head of Rheumatology/Clinical Immunology at University Hospital Wuerzburg, Department of Internal Medicine II

Presentation(s):

  • 1450: The Novel Digital Therapeutic Axia Improves Disease Activity, Functionality, and Quality of Life in Axial Spondyloarthritis Patients: Results from a Randomized Controlled Trial (Bechterew-App Trial)

    Monday, October 27, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): AbbVie: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), travel expenses (Ongoing); Alfasigma: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), travel expenses (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), travel expenses (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chugai: Grant/Research Support (Ongoing); Eli Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); EUSA-Pharma: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Johnson&Johnson: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), travel expenses (Ongoing); Merck/MSD: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); onkowissen.de: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Advisor or Review Panel Member (Ongoing); SOBI: Advisor or Review Panel Member (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), travel expenses (Ongoing)